EBMT 2021 | Looking forward to the EBMT 2021 Annual Meeting
Nicolaus Kröger, MD, University Medical Center Hamburg, Hamburg, Germany, shares key themes that will be addressed at 47th EBMT Annual Meeting, which will take place virtually on March 14th-17th, 2021. Prof. Kröger highlights the latest developments in haploidentical transplantation, the new agents for graft versus host disease (GvHD), and genome-editing therapy. The EBMT Annual Meeting includes a vast nurses’ program as well as sessions for young investigators. This interview was recorded during an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
Transcript (edited for clarity)
So, this year, due to the pandemic, due to the ongoing COVID-19 pandemic, we have to do our next annual meeting in March also as a completely virtual meeting. But we are happy that we have so many registrations, so more than 5,000 registration, at least so far. So, this is still ongoing. We will present an exciting program. So, we have all these different stakeholders on board. We will present a novel maintenance strategy post-transplant...
So, this year, due to the pandemic, due to the ongoing COVID-19 pandemic, we have to do our next annual meeting in March also as a completely virtual meeting. But we are happy that we have so many registrations, so more than 5,000 registration, at least so far. So, this is still ongoing. We will present an exciting program. So, we have all these different stakeholders on board. We will present a novel maintenance strategy post-transplant. We will present some new ideas about artificial intelligence in stem cell transplantation.
We will have dedicated session to the COVID-19. This is a very hot topic, how we deal with this patient, what about vaccination, all the problems we have in Europe, but also around the world. We have a dedicated Patient, Family and Donor Day dedicated only to patients, donors and their families. We have a dedicated Cell Therapy Day, which deals mainly with CAR T-cells, but also with a new field of genome editing therapy and T-cell receptor therapy. We have a dedicated session for transplant and search coordinators, and a statistical symposium for those who are interesting to do their own statistical work.
So really this will be an exciting meeting and we have also a joint session with our partner organization like EHA, CIBMTR, ADST, the Korean Society, but also the WBMT and the Asia-Pacific Bone Marrow Transplantation to have common session to share our knowledge, to share our experience and to provide the most cutting-edge new technology in stem cell transplantation and cellular therapy.
Read more...
